PMC:99044 / 2215-2862 JSONTXT

{"project":"2_test","denotations":[{"id":"11897013-8597995-9155450","span":{"begin":147,"end":148},"obj":"8597995"},{"id":"11897013-9472202-9155451","span":{"begin":149,"end":150},"obj":"9472202"},{"id":"11897013-9737513-9155452","span":{"begin":298,"end":299},"obj":"9737513"},{"id":"11897013-9737513-9155453","span":{"begin":462,"end":463},"obj":"9737513"},{"id":"11897013-10396667-9155454","span":{"begin":464,"end":466},"obj":"10396667"}],"text":"Results from different studies report that patients with AF have a mortality rate about twice that of age- and sex-matched individuals without AF [8,9]. In the Framingham Heart study, the excess mortality associated with AF persisted after adjustment for the preexisting cardiovascular conditions [2]. Aging, diabetes, heart failure and myocardial infarction were found to be independent risk factors for cardiovascular mortality among patients with chronic AF [2,10]. However, the information on the impact of chronic AF on mortality in the general population is limited, and to the best of our knowledge no study with UK data has been published."}